Jafron Biomedical Co. Ltd. (300529)
Market Open
15 Oct, 07:00 AM
XSHE XSHE Primary ¥
14. 85
-0.1
-0.6689%
¥
16.2B Market Cap
- P/E Ratio
3.2% Div Yield
3.93M Volume
- Eps
¥ 14.95
Previous Close Want to track 300529 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jafron Biomedical Co. Ltd. (300529) Statistics
Valuation metrics
Market Cap 16.2B
Enterprise value 11.65B
Trailing P/E (ttm) 22.47
Forward P/E -
PEG ratio -1.17
Price/Sales (ttm) 6.32
Price/Book (mrq) 3.44
Enterprise Value/Revenue 6.1
Enterprise Value/EBITDA 14.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.11M
Average volume (90 days) 7.33M
Price summary
52-Week low 14.73
52-Week high 21.96
Beta -
50-Day moving average 15.34
200-Day moving average 16.98
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.52
Trailing annual dividend yield 0.0344%
5-Year annual dividend yield -
Payout ratio 0.81
Dividend Date 1 Jun 2026
Ex-Dividend Date 1 Jun 2026
Last split factor 1:1
Last split Date 20 May 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.27%
Operating margin 0.35%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.43
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.67
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.03
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 2.11%
Book value per share (mrq) 4.39
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
